Group 1: Investor Relations Activity - The investor relations activity was held on September 19, 2025, from 15:30 to 17:00 [2] - The event was conducted online via the "Panorama Roadshow" website [2] - Participants included the company's Chairman and General Manager, Chen Jianming, and other senior executives [2] Group 2: Key Issues Addressed - Investors raised concerns about the company's long-term low stock price and the strategy to enhance market value [2] - The management emphasized the importance of stable business development and effective operational management [2] - The company has completed two phases of stock repurchase, indicating a commitment to improving shareholder value [2] Group 3: Strategic Initiatives - The company has formed a dual-main business model through mergers and acquisitions, showing significant results [2] - Management believes that the market value will eventually align with the company's intrinsic value [2]

Core Viewpoint - Mingchen Health's stock price has experienced a decline of 6.34% year-to-date, with a recent drop of 2.04% on September 19, 2023, indicating potential challenges in market performance [1][2]. Company Overview - Mingchen Health, established on December 14, 1994, and listed on December 18, 2017, is located in the Lian Nan Industrial Zone, Chenghai District, Shantou City, Guangdong Province. The company specializes in the research, production, and sales of health care products, including shampoos, conditioners, shower gels, gel water, and skincare products [2]. - The company's revenue composition is as follows: 76.84% from online games, 23.09% from daily chemical products, and 0.07% from other sources [2]. Financial Performance - For the first half of 2025, Mingchen Health reported a revenue of 712 million yuan, reflecting a year-on-year growth of 7.07%. However, the net profit attributable to shareholders decreased by 31.97% to 41.06 million yuan [2]. - Since its A-share listing, Mingchen Health has distributed a total of 151 million yuan in dividends, with 46.57 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders for Mingchen Health increased by 2.88% to 18,800, with an average of 14,063 circulating shares per person, a decrease of 2.80% [2]. - Notable institutional holdings include Huaxia Industry Prosperity Mixed Fund, which is the fourth largest shareholder with 5.2765 million shares, an increase of 1.6392 million shares from the previous period [3].

Market Overview - On September 18, the gaming sector declined by 1.56%, with Xinghui Entertainment leading the drop [1] - The Shanghai Composite Index closed at 3831.66, down 1.15%, while the Shenzhen Component Index closed at 13075.66, down 1.06% [1] Individual Stock Performance - Xinghui Entertainment (300043) closed at 7.17, down 6.88%, with a trading volume of 2.0662 million shares and a turnover of 1.518 billion yuan [2] - Other notable declines include: - Shenzhou Taiyue (300002) down 4.95% to 14.20 with a turnover of 1.763 billion yuan [2] - Bingchuan Network (300533) down 4.55% to 40.52 with a turnover of 994 million yuan [2] - Conversely, Xunyou Technology (300467) saw an increase of 5.61%, closing at 27.10 with a turnover of 927 million yuan [1] Capital Flow Analysis - The gaming sector experienced a net outflow of 1.72 billion yuan from major funds, while retail investors contributed a net inflow of 1.439 billion yuan [2] - Speculative funds saw a net inflow of 281 million yuan into the gaming sector [2]

Group 1 - The company announced the election of Mr. Liang Jinhui as the employee representative director of the fourth board of directors, effective from the date of the employee representative assembly approval until the end of the board's term [1][3][4] - Mr. Liang was previously a non-employee representative director and his election does not change the total number of board members, which remains compliant with relevant laws and regulations [1][4] - The company confirmed that the number of senior management personnel and employee representative directors does not exceed half of the total number of directors, adhering to legal requirements [1] Group 2 - The company will participate in the 2025 online collective reception day for investors organized by the Guangdong Securities Regulatory Bureau and the Guangdong Listed Companies Association, aimed at enhancing communication with investors [5][6] - The event will be held online on September 19, 2025, from 15:30 to 17:00, where company executives will discuss performance, governance, development strategy, and sustainability with investors [5][6] Group 3 - The company held its first temporary shareholders' meeting on September 16, 2025, with a total of 119 shareholders and representatives attending, representing 43.1356% of the total shares [10][15] - The meeting adopted several resolutions, including the approval of the three-year dividend plan and amendments to the company's articles of association, with overwhelming support from shareholders [19][20][24] - The company will no longer have a supervisory board, and the previous members will not hold any shares in the company, ensuring compliance with relevant regulations [24][32]

Group 1 - The company Mingchen Health (002919) announced the election of Mr. Liang Jinhui as the employee director of the fourth board of directors during the employee representative meeting held on September 16, 2025 [1]

证券代码：002919 证券简称：名臣健康 公告编号：2025-035 名臣健康用品股份有限公司 关于参加广东辖区 2025 年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 名臣健康用品股份有限公司 董事会 二〇二五年九月十六日 为进一步加强与投资者的互动交流，名臣健康用品股份有限公司（以下简称 "公司"）将参加由广东证监局、广东上市公司协会联合举办的"向新提质 价 值领航——2025 年广东辖区投资者集体接待日暨辖区上市公司中报业绩说明 会"，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP, 参与本次互动交流，活动时间为 2025 年 9 月 19 日（周五）15:30-17:00。 届时公司高管将在线就公司业绩、公司治理、发展战略、经营状况和可持续 发展等投资者关心的问题，与投资者进行沟通与交流，欢迎广大投资者踊跃参与！ 特此公告。 ...

根据《公司法》《深圳证券交易所上市公司自律监管指引第 1 号—主板上市 公司规范运作》及《上市公司章程指引》等法律法规、规范性文件和《名臣健康 用品股份有限公司章程》等相关规定，名臣健康用品股份有限公司（以下简称"公 司"）于 2025 年 9 月 16 日召开职工代表大会，经与会职工代表选举并审议，同 意选举梁锦辉先生为公司第四届董事会职工董事（简历附后），任期自本次职工 代表大会审议通过之日起至公司第四届董事会任期届满之日止。 证券代码：002919 证券简称：名臣健康 公告编号：2025-034 名臣健康用品股份有限公司 关于选举职工代表董事的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 梁锦辉原为公司第四届董事会非职工代表董事，本次选举完成后，其变更为 公司第四届董事会职工代表董事，公司第四届董事会构成人员不变。 本次选举职工代表董事工作完成后，公司兼任高级管理人员以及由职工代表 担任的董事人数未超过公司董事总数的二分之一，符合相关法律法规及《公司章 程》的规定。 特此公告。 名臣健康用品股份有限公司 董事会 二〇二五年九月十六日 附件： 梁锦 ...

证券代码：002919 证券简称：名臣健康 公告编号：2025-033 名臣健康用品股份有限公司 2025 年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现否决议案的情形。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 1、会议召开情况 （1）现场会议召开时间：2025 年 9 月 16 日（星期二）下午 13:30 （2）网络投票时间：2025 年 9 月 16 日 出席本次股东大会的股东及股东代理人共 119 人，代表公司股份数为 114,967,669 股，占公司股份总数的 43.1356%。其中，出席本次股东大会的中小投 资者（即除公司董事、监事、高级管理人员以及单独或者合计持有公司 5%以上股份 的股东以外的其他股东）共 116 人，代表公司有表决权股份数为 18,778,537 股， 占公司有表决权股份总数的 7.0457%。 （2）现场会议出席情况： 出席现场会议的股东及股东授权委托代表共 5 人，代表有表决权的股份数为 104,523,548 股，占 ...

北京市君泽君（深圳）律师事务所 关于名臣健康用品股份有限公司 2025 年第一次临时股东大会的法律意见书 深圳市福田区金田路4028号荣超经贸中心28层、29层 邮政编码：518035 电话：（0755）33988188 28&29 Floor, Rongchao Economic Trade Center, No.4028 Jintian Rd, Futian District,Shenzhen 518035 Tel：（0755）33988188 北京市君泽君（深圳）律师事务所 关于名臣健康用品股份有限公司 2025 年第一次临时股东大会的法律意见书 致：名臣健康用品股份有限公司 名臣健康用品股份有限公司（以下简称"公司"）2025 年第一次临时股东大会 （以下简称"本次股东大会"）于 2025 年 9 月 16 日 13：30 召开，北京市君泽君（深 圳）律师事务所（以下简称"本所"）接受公司的委托，指派相关律师（以下简称"本 所律师"）出席会议，并依据中国证券监督管理委员会（以下简称"中国证监会"） 《上市公司股东会规则》（以下简称"《股东会规则》"）的要求发表法律意见并出 具本法律意见书。 为出具本法 ...

Core Viewpoint - Mingchen Health (002919) reported mixed financial results for the first half of 2025, with revenue growth but a significant decline in net profit compared to the previous year [1] Financial Performance - Total revenue for the first half of 2025 reached 712 million yuan, a year-on-year increase of 7.07% [1] - Net profit attributable to shareholders was 41.06 million yuan, down 31.97% year-on-year [1] - In Q2 2025, total revenue was 350 million yuan, reflecting a 15.64% increase year-on-year, while net profit for the quarter rose by 82.07% to 28.35 million yuan [1] - Gross margin decreased to 53.74%, down 14.6% year-on-year, and net margin fell to 5.77%, down 36.48% [1] - Total expenses (selling, administrative, and financial) amounted to 314 million yuan, accounting for 44.17% of revenue, a slight decrease of 2.65% year-on-year [1] Balance Sheet and Cash Flow - The company reported a significant accounts receivable issue, with accounts receivable amounting to 540.59% of net profit [1][2] - Cash and cash equivalents decreased by 13.62% to 112 million yuan [1] - Interest-bearing debt increased by 99.25% to 39.86 million yuan [1] - Earnings per share dropped to 0.15 yuan, a decrease of 31.96% year-on-year [1] Business Model and Investment Returns - The company's return on invested capital (ROIC) was 5.53%, indicating average capital returns [2] - Historical data shows a median ROIC of 13.96% since the company went public, with the lowest ROIC recorded in 2022 at 2.65% [2] - The company's performance relies heavily on research and marketing efforts, necessitating further analysis of these drivers [2] Fund Holdings - The largest fund holding Mingchen Health is the Huaxia Vision Growth Mixed A Fund, with 2.76 million shares held [3] - The fund's current size is 622 million yuan, with a recent net value of 1.2917, reflecting a 0.68% decline from the previous trading day but a 106.28% increase over the past year [3]